When I started out here I said that a year ago when I first got in to NNVC I did some very basic research and my impression from what I read was that a lot of people were working with similar nano particles but that the problem facing everyone was keeping the formulates intact in solution. I bought on a bet that NNVC might be the people to solve that problem. If not it goes a long way to explaining the delays. Maybe when they make a batch it works wonders but when they come to the lab the next day it is mush.
The relationship with Theracour was explained to me in the beginning (by a cheerleader) as a shield to prevent big pharma from attacking NNVC with a cheap offering below the true value of the ultimate value of the discovery, if indeed the process could be continued for all viruses. Likewise the special voting shares that make a takeover impossible without the Principal's consent. All this is also possible as part of a scenario to deceive.
Market Data 
Markets 
AI
